CII
VIR icon

Capital International Inc’s Vir Biotechnology VIR Stock Holding History

Capital International Inc’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,681
Closed -$374K – 293
2022
Q2 		$374K Sell
14,681
-24,777
-63% -$578K 0.01% 276
2022
Q1 		$1.01M Sell
39,458
-18,742
-32% -$556K 0.01% 268
2021
Q4 		$2.44M Buy
58,200
+1,209
+2% +$47.4K 0.02% 245
2021
Q3 		$2.48M Sell
56,991
-3,497
-6% -$151K 0.02% 244
2021
Q2 		$2.86M Sell
60,488
-5,098
-8% -$232K 0.03% 247
2021
Q1 		$3.36M Sell
65,586
-17,553
-21% -$946K 0.03% 233
2020
Q4 		$2.23M Buy
83,139
+3,634
+5% +$118K 0.02% 244
2020
Q3 		$2.73M Buy
+79,505
New +$3.42M 0.03% 206

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return